{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:31:01Z","timestamp":1773210661536,"version":"3.50.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Biotechnology Research Center and Pharmaceutical Research Center"},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences (MUMS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Center for Research and Training in Skin Diseases and Leprosy"},{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences (TUMS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nanotechnology Research Center, MUMS, Iran","award":["84411"],"award-info":[{"award-number":["84411"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.actatropica.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T16:30:24Z","timestamp":1460133024000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB\/c mice-based experimental setting"],"prefix":"10.1016","volume":"159","author":[{"given":"Fatemeh","family":"Fakhraee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Badiee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Hoda","family":"Alavizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Amir","family":"Jalali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Chavoshian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Khamesipour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereidoun","family":"Mahboudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud Reza","family":"Jaafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2016.04.004_bib0005","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.exppara.2012.06.014","article-title":"The role of liposome\u2013protamine\u2013DNA nanoparticles containing CpG oligodeoxynucleotides in the course of infection induced by Leishmania major in BALB\/c mice","volume":"132","author":"Alavizadeh","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.imlet.2005.01.009","article-title":"T helper (h) 1\/Th2 and Leishmania: paradox rather than paradigm","volume":"99","author":"Alexander","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.vaccine.2012.11.068","article-title":"Micro\/nanoparticle adjuvants for antileishmanial vaccines: present and future trends","volume":"31","author":"Badiee","year":"2013","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.actatropica.2016.04.004_bib0020","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1517\/17425247.5.7.789","article-title":"Recent developments in leishmaniasis vaccine delivery systems","volume":"5","author":"Bhowmick","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0025","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni725","article-title":"IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB\/c mice","volume":"2","author":"Biedermann","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0020-7519(97)00169-0","article-title":"The immune response to Leishmania: mechanisms of parasite control and evasion","volume":"28","author":"Bogdan","year":"1998","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.provac.2009.07.019","article-title":"Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis","volume":"1","author":"Borja-Cabrera","year":"2009","journal-title":"Proced. Vaccinol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0040","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/14760584.2.5.705","article-title":"Vaccines in leishmaniasis: advances in the last five years","volume":"2","author":"Brodskyn","year":"2003","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0045","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0050","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0055","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.90.24.11473","article-title":"Effective immunization against cutaneous leishmaniasis with recombinant bacille calmette-guerin expressing the Leishmania surface proteinase gp63","volume":"90","author":"Connell","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0060","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.2999974","article-title":"Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene","volume":"230","author":"Coussens","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0065","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s00262-005-0685-2","article-title":"Liposome-polycation-DNA (LPD) particle as a carrier and adjuvant for protein-based vaccines: therapeutic effect against cervical cancer","volume":"54","author":"Cui","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0070","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0024-3205(00)00745-1","article-title":"Improvement of in vivo stability of phosphodiester oligonucleotide using anionic liposomes in mice","volume":"67","author":"De Oliveira","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0075","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/biohorizons\/hzp004","article-title":"Leishmania vaccines: from leishmanization to the era of DNA technology","volume":"2","author":"Dunning","year":"2009","journal-title":"Biosci. Horizon"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0080","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ijpara.2004.03.005","article-title":"Molecular characterization of a novel amastigote stage specific class I nuclease from Leishmania major","volume":"34","author":"Farajnia","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0085","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2249.2004.02702.x","article-title":"Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response","volume":"139","author":"Farajnia","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0090","series-title":"New Developments with Human and Veterinary Vaccines","first-page":"259","article-title":"The present and future of vaccination for cutaneous leishmaniasis","author":"Greenblatt","year":"1980"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0095","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0169-4758(88)90067-1","article-title":"Cutaneous leishmaniasis: the prospects for a killed vaccine","volume":"4","author":"Greenblatt","year":"1988","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0100","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.4049\/jimmunol.137.11.3608","article-title":"Passive transfer of Leishmania lipopolysaccharide confers parasite survival in macrophages","volume":"137","author":"Handman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0110","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.micinf.2008.06.002","article-title":"Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice","volume":"10","author":"Iborra","year":"2008","journal-title":"Microbes Infect."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0115","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.vaccine.2006.04.062","article-title":"Immune response and protection assay of recombinant major surface glycoprotein of Leishmania (rgp63) reconstituted with liposomes in BALB\/c mice","volume":"24","author":"Jaafari","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0120","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1016\/j.vaccine.2007.05.009","article-title":"The role of CpG ODN in enhancement of immune response and protection in BALB\/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63) encapsulated in cationic liposome","volume":"25","author":"Jaafari","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0125","first-page":"140","article-title":"Epidemiology of cutaneous leishmaniasis in Iran: B. Khorassan Part V: report on a focus of zoonotic cutaneous leishmaniasis in Esferayen","volume":"69","author":"Javadian","year":"1975","journal-title":"Bull. Soc. Pathol. Exot. Filiales"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/0092-8674(93)90542-X","article-title":"The relationship of IL-4-and IFN\u03b3-producing T cells studied by lineage ablation of IL-4-producing cells","volume":"75","author":"Kamogawa","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0135","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1128\/IAI.73.6.3823-3827.2005","article-title":"CD4+ T cells play a dominant role in protection against new world leishmaniasis induced by vaccination with the P-4 amastigote antigen","volume":"73","author":"Kar","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0140","first-page":"423","article-title":"Leishmaniasis vaccine candidates for development: a global overview","volume":"123","author":"Khamesipour","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0145","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1073\/pnas.93.7.2879","article-title":"CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6 interleukin 12, and interferon gamma","volume":"93","author":"Klinman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1146\/annurev.immunol.20.100301.064842","article-title":"CPG motifs in bacterial dna and their immune effects","volume":"20","author":"Krieg","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.gt.3300482","article-title":"In vivo gene transfer via intravenous administration of cationic lipid\u2013protamine\u2013DNA (LPD) complexes","volume":"4","author":"Li","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0165","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.1073\/pnas.0506638102","article-title":"The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells","volume":"102","author":"Lugo-Villarino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1568008023340631","article-title":"Vaccination against Leishmania infections","volume":"2","author":"Mauel","year":"2002","journal-title":"Curr. Drug. Targets Immune. Endocr. Metabol. Disord."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.coi.2010.04.004","article-title":"New adjuvants for human vaccines","volume":"22","author":"Mbow","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0180","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1128\/IAI.68.10.5595-5602.2000","article-title":"Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library","volume":"68","author":"Melby","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0185","doi-asserted-by":"crossref","first-page":"e0003914","DOI":"10.1371\/journal.pntd.0003914","article-title":"Efficacy of recombinant canine distemper virus expressing Leishmania antigen against Leishmania challenge in dogs","volume":"9","author":"Miura","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Modabber","year":"1995","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0195","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijantimicag.2010.06.024","article-title":"Leishmaniasis vaccines: past, present and future","volume":"36","author":"Modabber","year":"2010","journal-title":"Int. J. Antimicrob. agents"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0200","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2004.03.058","article-title":"Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-shahr district, IR Iran","volume":"22","author":"Mohebali","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0205","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.vetimm.2014.01.011","article-title":"Primary vaccination with the LiESP\/QA-21 vaccine (CaniLeish\u00ae) produces a cell-mediated immune response which is still present 1 year later","volume":"158","author":"Moreno","year":"2014","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0210","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.7725103","article-title":"Expression cloning of a protective Leishmania antigen","volume":"268","author":"Mougneau","year":"1995","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.actatropica.2016.04.004_bib0215","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert. Rev. Vaccines"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0220","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1086\/374419","article-title":"Vaccines, vaccination, and vaccinology","volume":"187","author":"Plotkin","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0225","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.4049\/jimmunol.150.6.2322","article-title":"Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis","volume":"150","author":"Rachamim","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0230","first-page":"601","article-title":"Vaccination against cutaneous leishmaniasis using sonicated and X-ray irradiated promastigote of Leishmania major in murine models","volume":"15","author":"Rahdar","year":"2015","journal-title":"Biochem. Cell. Arch."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0235","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20020147","article-title":"Vaccination with heat-killed Leishmania antigen or recombinant leishmanial protein and CpG oligodeoxynucleotides induces long-term memory CD4+ and CD8+ T cell responses and protection against Leishmania major infection","volume":"195","author":"Rhee","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0240","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nri933","article-title":"The immunology of susceptibility and resistance to Leishmania major in mice","volume":"2","author":"Sacks","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0245","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1016\/j.vaccine.2012.03.040","article-title":"Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis","volume":"30","author":"Shargh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0250","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.vaccine.2012.03.068","article-title":"Leishmaniasis: vaccine candidates and perspectives","volume":"30","author":"Singh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S1387-2656(04)10007-0","article-title":"DNA vaccines and their application against parasites\u2013promise: limitations and potential solutions","volume":"10","author":"Smooker","year":"2004","journal-title":"Biotechnol. Annu. Rev."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0260","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/IAI.63.9.3559-3566.1995","article-title":"Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis","volume":"63","author":"Soong","year":"1995","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0265","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.vaccine.2005.12.012","article-title":"From genome to vaccines for leishmaniasis: screening 100 novel vaccine candidates against murine Leishmania major infection","volume":"24","author":"Stober","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0270","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","article-title":"Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis","volume":"126","author":"Taswell","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0275","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0280","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2016.04.004_bib0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0166-6851(97)00115-1","article-title":"Molecular characterization of the heat-inducible LmSTI1 protein of Leishmania major","volume":"89","author":"Webb","year":"1997","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0290","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s002620100227","article-title":"Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses","volume":"50","author":"Whitmore","year":"2001","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.addr.2008.12.014","article-title":"Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy","volume":"61","author":"Wilson","year":"2009","journal-title":"Ad. Drug. Deliv. Rev."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0300","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase: ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.actatropica.2016.04.004_bib0305","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/108497801753354311","article-title":"Cationic liposomes enhance cellular\/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells","volume":"16","author":"Zhang","year":"2001","journal-title":"Cancer Biother. Radiopharm."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16301656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16301656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:41:48Z","timestamp":1718466108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X16301656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":61,"alternative-id":["S0001706X16301656"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.04.004","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coadminstration of L. major amastigote class I nuclease (rLmaCIN) with LPD nanoparticles delays the progression of skin lesion and the L. major dissemination to the spleen in BALB\/c mice-based experimental setting","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}